CLINICAL_TRIALS trial_result · 2011-08-30

Clinical Trial Update: A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer [Phase 2]

This update reports the completion of a Phase 2 trial examining thymidylate synthase expression in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-08-30